
IndraLab
Statements
KCNQ1 inhibits potassium(1+). 9 / 9
|
9
reach
"Some pleiotropic KCNQ1 variants in humans can simultaneously increase insulin secretion in the pancreas, reduce serum potassium upon oral glucose challenge, and cause long QT syndrome, putting individuals at risk of sudden, uncontrollable, arrhythmias which may lead to fainting or sudden death 35."